Just three different COVID-19 vaccines are available in the United States after the U.S. Food and Drug Administration (FDA) on June 1 revoked the authorization for the Johnson & Johnson shot.
Regulators made the move because of a request from Janssen, a Johnson & Johnson’s subsidiary that makes the vaccine.
Janssen “has informed the FDA that the last lots of the Janssen COVID-19 vaccine purchased by the United States government have expired, that there is no demand for new lots of the Janssen COVID-19 vaccine in the United States, and that Janssen Biotech, Inc does not intend to update the strain composition of this vaccine to address emerging variants,” Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a letter to Janssen executive Ruta Walawalkar….